Viewer

    Emergency Lung AI Suite for COVID-19

    Fast access to lung quantification results and tissue characterization

    Emergency Lung AI Suite 

    Our rapid response platform allows physicians to upload cases and receive fast quantification results, regardless of where they sit - the emergency department, radiology, pulmonology, or at home. The EnvoyAI Emergency Lung AI Suite delivers newly enhanced segmentation data science and automated measurement capabilities within a guided workflow for the disease progression assessment and quantification of COVID-19 and other lung related illness.*​
    cloud emergency lung ai suite

    Improving Patient Outcomes through AI-driven Insights​

    • Achieve faster and better-informed care ​leveraging purpose built and easy-to-consume interpretation solutions.​
    • Strengthen clinical ​decision making and diagnosis with AI-driven imaging insights in immersive and intuitive dashboards.​
    • Increase confidence ​by using technology noted as the ground truth for accuracy and precision in advanced image processing.​

    Fast Access to Lung Quantification Results & Tissue Characterization​

    • Physicians can more quickly & effectively identify disease impact, determine progression or improvement, and suggest additional or follow-up treatment required for better patient outcomes.
    • Reduce physician stress and fatigue by eliminating repetitive, manual tasks. ​​
    • No installation required – immediate access.

    LungAI Workflow Key Features

    The LungAI workflow leverages TeraRecon's data science expertise to rapidly deliver an automated lung experience that delivers zero-click segmentation and histogram results based on physician-customized thresholds. The results of these studies are available for review and adjustment prior to image archival - maintaining physician control. 
    WebUploader2032_1064
    Web-Based Upload and Anonymization
    Viewer
    Web-based, Responsive Design
    Mobile Viewer Study Select_1500_1080-1-1-1
    Mobile Support**
    ViewerImageOnly-Overlay
    Automatic lung assessment (segmentation & classification)
    VolumeHisto
    AI Results Explorer: Review, Adjust & Re-Run Capabilities
    Option
    Email notification of available results (HIPAA compliant)
    emergencyai suite

    Take a Step-by-Step Tour

    Our rapid response platform allows physicians to upload cases and receive fast quantification results, regardless of where they sit - the emergency department, radiology, pulmonology, or at home.

    Request Access

    The FCC Telehealth Program

    The Federal Communications Commission has unveiled a new $200 million program to help fund telehealth programs for qualifying providers during the COVID-19 pandemic.

    Apply and ensure your COVID-19 based technology needs are covered by available funds from the CARES Act. According to FCC officials, there are three steps interested providers can take immediately. 

    View FCC Public Notice

    Universal Service Administrative Company

    Obtain eligibility determination from the Universal Service Administrative Company for each health care provider site that is included in the application.

    FCC Registration Number

    All applicants, like all other entities doing business with the Commission, must register for an FRN in the Commission Registration System (CORES).

    System for Award Management

    Only those registered through the System for Award Management will be able to receive funding. If not registered, please submit an application to get the registration started.

    FREE GUIDE: Download Our FCC Covid-19 TeleHealth Program Quick Guide

    Download TeleHealth Program Quick Guide
    ViewerImageOnly-MPRAndMIP

    Ready to Get Started?

    Sign Up For a Free Account

    Get Started

     

    *The following are important statements regarding the use of this tool:

    • Volumetric histogram and lung segmentation functionality are FDA cleared features of Intuition. This functionality is not FDA cleared specifically for COVID-19. It must only be used as an aid and that final interpretation should be performed by a licensed healthcare practitioner with the appropriate training.
    • The results should not be used for screening and the software does not provide specific disease detection and should not be solely or primarily relied upon to diagnose or treat COVID-19.
    • This device is not indicated for the diagnosis of COVID-19 and that in vitro diagnostic testing is currently the only definitive method to diagnose COVID-19.
    • This tool is available by specific licenses only.
    • The default thresholds are generalized recommendations and limits for device performance when used in an U.S. population. The image analysis should only be used as an aid and the final interpretation should be performed by a licensed healthcare practitioner with the appropriate training.
    • Research use only in Europe

    **Not for diagnose use on mobile device​

    TeraRecon, Inc

    TeraRecon Headquarters
    4309 Emperor Blvd, Suite 310
    Durham, NC 27703 
    Tel: 650.372.1100
    Fax: 650.372.1101
    info@terarecon.com 

    Additional Resources

    Subscribe to our newsletter

    ©2016-2020 Terarecon, Inc. All Rights Reserved.